Filter
549
Filtered Results: 549
Text search:
Parasitology
Featured
Recommendations
48
New Publications
157
Language
Document type
No document type
268
Studies & Reports
126
Guidelines
86
Manuals
24
Strategic & Response Plan
15
Training Material
9
Infographics
7
Fact sheets
6
Resource Platforms
5
Situation Updates
2
Online Courses
1
Countries / Regions
Senegal
35
Global
32
Africa
19
Latin America and the Carribbean
18
Uganda
16
Colombia
12
Ethiopia
12
Kenya
11
Tanzania
11
Congo, Democratic Republic of
11
Mozambique
10
Brazil
10
Nepal
9
Paraguay
9
Benin
8
Venezuela
8
Zambia
8
Cameroon
7
Burkina Faso
7
Malawi
7
East and Southern Africa
7
Bolivia
7
India
7
Sierra Leone
6
Nigeria
6
West and Central Africa
6
Middle East and North Africa
6
Bangladesh
6
Angola
6
Myanmar / Burma
6
Ghana
5
Peru
5
Zimbabwe
5
Cambodia
5
Western and Central Europe
5
Argentina
5
Liberia
5
Haiti
4
South Africa
4
South Sudan
4
Rwanda
3
Philippines
3
Guinea
3
South–East Asia Region
3
Uruguay
3
Botswana
3
Madagascar
3
North Macedonia
2
Chile
2
Lebanon
2
Eastern Europe
2
Namibia
2
Indonesia
2
Ecuador
2
Eswatini/ Swaziland
2
Thailand
1
El Salvador
1
Turkey
1
Syria
1
Iran
1
Albania
1
Laos
1
Morocco
1
Bulgaria
1
Italy
1
USA
1
Dominican Republic
1
Jordan
1
Germany
1
Saudi Arabia
1
North America
1
Tunisia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Papua New Guinea
1
Sudan
1
Greece
1
Georgia
1
Chad
1
Iraq
1
Somalia
1
Cuba
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
97
Pharmacy & Technologies
51
Public Health
31
Women & Child Health
11
Capacity Building
9
Key Resources
6
Toolboxes
NTDs
110
Planetary Health
17
AMR
13
Rapid Response
12
HIV
12
Ebola
7
Mental Health
6
TB
6
Disability
6
COVID-19
6
Pharmacy
6
Natural Hazards
3
Caregiver
3
Zika
3
Global Health Education
3
Refugee
2
Health Financing Toolbox
2
Cholera
1
Conflict
1
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Lignes directrices de l'OMS sur le paludisme
recommended
Les Lignes directrices de l'OMS sur le paludisme rassemblent les recommandations les plus récentes de l'Organisation pour le paludisme dans une plateforme en ligne conviviale et facile à naviguer.
Les Lignes directrices de l'OMS sur le paludisme remplacent 2 publications précédentes de l'OMS: l...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National health systems in order to meet community needs and ...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
La Stratégie de riposte face à la résistance aux antipaludiques en Afrique est un document technique de sensibilisation qui se fonde sur les bases factuelles les plus solides dont on dispose et vise à réduire au maximum la menace et l’impact de la résistance aux antipaludiques de Plasmodium ...
El desarrollo, desde 1991, de las Iniciativas Subregionales de Control de la Enfermedad de Chagas, y los avances de conocimiento en materia de diagnóstico y manejo de la infección/enfermedad de Chagas, llevan a la necesidad ética, y operativamente imperiosa, de estructurar el diagnóstico, atenci...
El proyecto “Abordar las Enfermedades Infecciosas Desatendidas (EID) y las arbovirosis en el Chaco Paraguayo” ejecutado en el period 2017-2018 en el Chaco paraguayo por el Ministerio de Salud Pública y Bienestar Social de Paraguay (MSPyBS) con la cooperación técnica de la Representación en e...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
